Pierre Gravier Ptc Therapeutics, Inc. (PTCT) insider trading activity

Pierre Gravier is CHIEF FINANCIAL OFFICER of PTC THERAPEUTICS, INC.. Currently has a direct ownership of 71,920 shares of PTCT, which is worth approximately $3.26 Million. The most recent transaction as insider was on Jul 15, 2025, when has been sold 2,516 shares (Common Stock) at a price of $49.46 per share, resulting in proceeds of $124,441. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 71.9K

3.38% 3M change

34.35% 12M change

Total Value Held $3.26 Million

Pierre Gravier Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 15 2025	SELL Open market or private sale	$124,441 $49.46 p/Share	2,516 Reduced 3.38%	71,920 Common Stock
Feb 20 2025	SELL Open market or private sale	$58,490 $50.12 p/Share	1,167 Reduced 1.54%	74,436 Common Stock
Feb 19 2025	SELL Open market or private sale	$58,516 $50.1 p/Share	1,168 Reduced 1.52%	75,603 Common Stock
Jan 03 2025	BUY Grant, award, or other acquisition	-	22,500 Added 22.67%	76,771 Common Stock
Jul 16 2024	SELL Open market or private sale	$77,191 $34.02 p/Share	2,269 Reduced 4.07%	53,531 Common Stock
Feb 15 2024	BUY Grant, award, or other acquisition	-	22,100 Added 28.37%	55,800 Common Stock
Dec 12 2023	BUY Open market or private purchase	$198,737 $25.81 p/Share	7,700 Added 18.6%	33,700 Common Stock
Jul 13 2023	BUY Grant, award, or other acquisition	-	26,000 Added 50.0%	26,000 Common Stock

Also insider at

SAVA

CASSAVA SCIENCES INC Healthcare

Director

Pierre Gravier

CHIEF FINANCIAL OFFICER

South Plainfield, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PTCT shares.

Notify only if

Value

Insider Trading

Get notified when an Ptc Therapeutics, Inc. insider buys or sells PTCT shares.

Notify only if

Operation

Value

Type

News

Receive news related to PTC THERAPEUTICS, INC.

Track Activities on PTCT

Account